Nasus Pharma NSRX
NYSE NSRX
$3.61 +0.02 (+0.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nasus Pharma (NSRX) Total Liabilities (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Total Liabilities of $1.45 million for Q2 2026, down 70.7% from $4.95 million a year earlier.

Analysis

Nasus Pharma (NSRX) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Total Liabilities of $2.24 million, down 43.1% from FY2024.

  • By year, Total Liabilities came in at $3.93 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Nasus Pharma 32.00 Mn 32.00 Mn - 1.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.45 Mn
Dec 31, 2025 2.24 Mn
Jun 30, 2025 4.95 Mn
Dec 31, 2024 3.93 Mn
API Access

Nasus Pharma Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NSRX&period=max&api_key=YOUR_API_KEY